Novavax Forecast and Stock Analysis
Technical NVAX stock analysis for February 15, 2019.
Novavax fell by -3.18% in the last day from $2.20 to $2.13 The price has fallen in 5 of the last 10 days and is down by -7.39% for this period. Volume has increased in the last day by 1.54 million shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 9.27 million shares bought and sold for approximately $19.74 million.
Close price at the end of the last trading day (Friday, 15th Feb 2019) of the NVAX stock was $2.13. This is 3.18% less than the trading day before Thursday, 14th Feb 2019.
During day the stock fluctuated 4.25% from a day low at $2.12 to a day high of $2.21.
30 day high of the NVAX stock price was $2.44 and low was $2.00.
90 day high was $2.58 and low was $1.63.
52 week high for the Novavax - $2.75 and low - $1.15.
Novavax lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.69% during the next 3 months and, with 90% probability hold a price between $2.23 and $3.14 at the end of this period.
There are few to none technical positive signals at the moment. Novavax holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $2.20 and $2.15. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday January 31, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Relative Strength Index (RSI)
RSI14 is 49 and the stock is currently not being overbought or oversold
Support & Resistance
Novavax finds support from accumulated volume at $2.05.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.09 between high and low, or 4.25%. For the last week, the stock has had a daily average volatility of 3.88%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
The Novavax stock holds several negative signals and despite the positive trend we believe Novavax will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.